Discovery & Development

A superbug vaccine could protect patients against multiple healthcare-associated infections at once

Clinical trials have improved greatly over the years, but there is still much to be done.

Researchers develop a new approach to mapping the individual heterogeneity of brain changes in mental disorders

In vivo animal models have brought much to the science behind the drug development industry, but how far behind are organ-on-a-chip models?

Experimental insomnia drug shows promise in alleviating opioid withdrawal symptoms and opioid-seeking behavior

After serving as Head of Research Development at Trinity College Dublin, Fiona Killard-Lynch became Director of Research and Innovation at NIBRT

Deepika Khedekar explores the unique environment of space and its implications for clinical research.

Howard Fillit shares his views on the historical research lag, the slim successes so far, and the target pathways that offer most hope

Ongoing issues in the Asian pharma sector prompt an unequivocal response from the FDA and the IPEC Federation.

Experts from Axolabs GmbH and Bruker Daltonics explain the benefits behind mass spectrometry for oligonucleotides in drug discovery